Interleukin 10 polymorphisms and cervical cancer risk : A meta-analysis

International Journal of Gynecological Cancer

Volumn 23, Issue 1, 2013, Pages 126-133

  Ni, Jing ^a   Ye, Yang ^b   Teng, Fang ^b   Wu, Qiang ^a  

^a JIANGSU CANCER HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; IL 10; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 10;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; HISPANIC; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CANCER;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84872292965     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318274b1a2     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-28.
3. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005; (32 suppl 1):S16-S24.
4. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology. 2001;103:131-136.
5. Maurer M, Kruse N, Giess R, et al. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol. 2000;104: 98-100.
6. Wang Q, Zhang C, Walayat S, et al. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol. 2011;158: 330-333.
7. Matsumoto K, Oki A, Satoh T, et al. Interleukin-10-1082 gene polymorphism and susceptibility to cervical cancer among Japanese women. Jpn J Clin Oncol. 2010;40:1113-1116.
8. Qi X, Ma X, Yang X, et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. 2010;123:499-506.
9. Wu W, Shen O, Qin Y, et al. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of male infertility: a meta-analysis. Int J Androl. 2012;35:18-24.
10. Zoodsma M, Nolte IM, Te Meerman GJ, et al. HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease. Int J Oncol. 2005;26:769-784.
11. Singh H, Jain M, Sachan R, et al. Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer. 2009;19:1190-1194.
12. Wu S. Study on the association between gene polymorphsims of IL-10 and susceptibility of HPV and cervical cancer [in Chinese]. Hebei Medical University. 2011.
13. Yu XM, Ma D, Wu SQ, et al. Relationship between polymorphisms of IL-10 gene and cervical cancer [in Chinese]. Chin J Nosocomiol. 2011;21:239-241.
14. Shekari M, Kordi-Tamandani DM, Malekzadeh K, et al. Effect of anti-inflammatory (IL-4, IL-10) cytokine genes in relation to risk of cervical carcinoma [published online ahead of print December 30, 2011]. Am J Clin Oncol. doi:10.1097/COC.0b013e31822d9c12.
15. Barbisan G, Perez LO, Contreras A, et al. TNF-alpha and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 2012.
16. Fernandes AP, Goncalves MA, Simoes RT, et al. A pilot case-control association study of cytokine polymorphisms in Brazilian women presenting with HPV-related cervical lesions. Eur J Obstet Gynecol Reprod Biol. 2008;140:241-244.
17. Ivansson EL, Gustavsson IM, Magnusson JJ, et al. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer. 2007;121:2451-2457.
18. Zoodsma M, Nolte IM, Schipper M, et al. Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer. 2005;:282-290.
19. Govan VA, Carrara HR, Sachs JA, et al. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2003;2:3.
20. Roh JW, Kim MH, Seo SS, et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 2002;184:57-63.
21. Stanczuk GA, Sibanda EN, Perrey C, et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer. 2001;94:792-794.
22. Liu Y, Xu LZ. Meta-analysis of association between GSTM1 gene polymorphism and cervical cancer. Asian Pac J Trop Med. 2012;5:480-484.
23. Deshpande A, Nolan JP, White PS, et al. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis. 2005;191: 969-976.
24. Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001;166:3915-3922.
25. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209-1220.